BrightFocus Foundation Expands Popular Alzheimer’s Information Series to Focus on Clinical Research
BrightFocus Foundation announces the expansion of its free, interactive information series, Zoom In on Dementia & Alzheimer’s, with the addition of four new live episodes in 2024 focused on demystifying clinical research with renowned research scientists.
The new episodes will walk participants through specific clinical trials and research studies for Alzheimer’s diagnostics, treatments, and lifestyle or other interventions. The goal is to help audiences understand how to find trials and studies in which they or their loved ones with specific conditions or concerns might participate.
“While every drug, diagnostic test, and technology used in medicine today was once tested in volunteers who participated in clinical research studies, there is still limited understanding of the value of clinical research, and recruitment for clinical research in Alzheimer’s disease remains challenging,” said BrightFocus President and CEO Stacy Pagos Haller. “The additional episodes of Zoom In will be pivotal toward broadening access to information about brain health research and sharing the value of this research.”
The expansion follows a record-breaking season of Zoom In on Dementia & Alzheimer’s. Since its launch in 2023, the program has garnered nearly 700,000 live and on-demand views. Episodes have explored ways to reduce Alzheimer’s risk, new treatments, and non-drug lifestyle or other interventions for the disease, and have featured world-renowned neurologists, scientists, and researchers on the cutting edge of Alzheimer’s diagnostics, treatments, and research tools. All previous episodes are available to watch on demand on the BrightFocus website and YouTube.
The first episode of Zoom In on Dementia & Alzheimer’s: Clinical Research is Tuesday, June 18 at 1 p.m. ET. Host Nancy Lynn, BrightFocus Foundation, will speak with leading scientists about two research opportunities that do not involve taking medications: the Emory Healthy Aging Study and the NeuroQuest study.
Participants can join by phone or by Zoom, and there will be a live Q&A where attendees can ask questions directly of guest experts James J. Lah, MD, PhD, Alice and Roy Richards Professor of Neurology and director of the Emory Cognitive Neurology Program at Emory University Brain Health Center and John Showalter, chief product officer and chief strategy officer at Linus Health.
Zoom In on Dementia & Alzheimer’s is supported in part by educational funding provided by Biogen, Lilly, and Genentech.
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, National Glaucoma Research, and Macular Degeneration Research — the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 50 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Don't miss out.
Receive Alzheimer's breakthrough news, research updates, and inspiring stories.